The co-evolution of the genome and epigenome in colorectal cancer

Andrea Sottoriva, Timon Heide, George D. Cresswell(ORCID), Inma Spiteri(Institute of Cancer Research), Claire Lynn, Javier Fernández-Mateos, Bingjie Chen, Luís Zapata, Kate Chkhaidze(Institute of Cancer Research), Daniel Nichol, Giulio Caravagna, Chela James, Maximilian Mossner(Queen Mary University of London), Christopher Kimberley(Queen Mary University of London), Jacob Househam(Queen Mary University of London), Alison Berner(Queen Mary University of London), Melissa Schmidt(ORCID), Eszter Lakatos(Queen Mary University of London), Ann‐Marie Baker(ORCID), Trevor A. Graham(Queen Mary University of London), Iros Barozzi(Imperial College London), Helena Costa(University College London), Miriam Mitchinson(University College London), Marnix Jansen(University College London), John Bridgewater(University College London), Manuel Rodriguez‐Justo(ORCID), Luca Magnani(ORCID), Daniele Ramazzotti(University of Milano-Bicocca), Darryl Shibata(University of Southern California)
Research Square
September 8, 2021
Cited by 2Open Access
Full Text

Abstract

Abstract Colorectal malignancies are a leading cause of cancer death. Despite large-scale genomic efforts, DNA mutations do not fully explain malignant evolution. Here we study the co-evolution of the genome and epigenome of colorectal tumours at single-clone resolution using spatial multi-omic profiling of individual glands. We collected 1,373 samples from 30 primary cancers and 9 concomitant adenomas and generated 1,212 chromatin accessibility profiles, 527 whole-genomes and 297 whole-transcriptomes. We found positive selection for DNA mutations in chromatin modifier genes and recurrent chromatin changes in regulatory regions of cancer drivers with otherwise no mutation. Genome-wide alterations in transcription factor binding accessibility involved CTCF, downregulation of interferon, and increased accessibility for SOX and HOX, indicating developmental genes reactivation. Epigenetic aberrations were heritable, distinguishing adenomas from cancers. Mutational signature analysis showed the epigenome influencing DNA mutation accumulation. This study provides a map of (epi)genetic tumour heterogeneity, with fundamental implications for understanding colorectal cancer biology.


Related Papers

No related papers found

Powered by citation graph analysis